Inappropriate outpatient antibiotic use in children insured by Kentucky Medicaid

Bethany A Wattles1, Kahir S Jawad1, Yana Feygin1

  • 1Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky.

Insights

Inappropriate antibiotic prescribing to children in Kentucky Medicaid is common, affecting nearly 21% of prescriptions. Rural children, those aged 0-2, and those with chronic conditions were more likely to receive unnecessary antibiotics.

Area of Science:

  • Pediatric Health
  • Pharmacology
  • Health Services Research

Background:

  • Antibiotic resistance is a growing public health concern.
  • Inappropriate antibiotic prescribing contributes to antibiotic resistance.
  • Understanding prescribing patterns in pediatric populations is crucial.

Purpose of the Study:

  • To identify risk factors for inappropriate antibiotic prescribing in children.
  • To analyze antibiotic prescribing appropriateness in a large pediatric Medicaid population.

Main Methods:

  • Retrospective analysis of Kentucky Medicaid medical and pharmacy claims data from 2017.
  • Identified antibiotic prescriptions and linked them to patient and provider characteristics.
  • Applied a classification scheme to determine the appropriateness of antibiotic prescriptions.

Main Results:

  • Over 779,000 antibiotic prescriptions were analyzed for 328,515 children.
  • 163,654 (21.0%) antibiotic prescriptions were deemed inappropriate.
  • Inappropriate prescribing was associated with rural residence, younger age (0-2 years), and chronic conditions.

Conclusions:

  • Inappropriate antibiotic prescribing to children in Kentucky Medicaid is prevalent.
  • Patient factors like rurality and chronic conditions are linked to inappropriate prescribing.
  • Claims data can inform provider feedback and policy development to improve antibiotic stewardship.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
975
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
75